Table 2 Toxicity

From: Phase II trial of short-term neoadjuvant docetaxel and complete androgen blockade in high-risk prostate cancer

Toxicity

Grade 1, n (%)

Grade 2, n (%)

Grade 3, n (%)

Grade 4, n (%)

Anaemia

42 (73)

1 (2)

  

Plaquetopenia

4 (7)

1 (2)

  

Neutropenia

10 (18)

4 (7)

  

Fluid retention

1 (2)

   

Alopecia

11 (20)

2 (4)

  

Nail toxicity

9 (16)

   

Rash

2 (4)

2 (4)

  

Mucositis

3 (6)

2 (4)

  

Diarrhoea

13 (23)

7 (12)

4 (7)

1(2)

Nausea/vomiting

10 (18)

8 (14)

  

Hepatic

10 (18)

12 (21)

7 (12)

 

Fatigue

13 (23)

8 (14)

  

Neurotoxicity

4 (7)